Announcement on Progress in A-share Repurchase
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/jiangsu-hengrui-pharmaceuticals-co-ltdannouncement-on-progress-in-a-share-repurchase
Jiangsu Hengrui Pharmaceuticals Co., Ltd. on 6ix
Earlier from Jiangsu Hengrui Pharmaceuticals
- Announcement on Obtaining Notice of Approval for Drug Clinical Trial
- Announcement on Inclusion of Drug in Breakthrough Therapy Designation List
- Announcement on Inclusion of Key Pharmaceutical Products of the Company in the National Essential Medicines List
- Jiangsu Hengrui Pharmaceuticals: Hengrui Pharma Announces Positive Topline Data from Two Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535
- Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion into the Priority Review Program
Later from Jiangsu Hengrui Pharmaceuticals
- Announcement on Obtaining Drug Registration Approval
- Announcement on Obtaining Orphan Drug Designation from the US FDA
- Indicative Announcement on Acceptance of Application for Drug Marketing Authorization
- Announcement on Implementation Result of Shares Repurchase and Share Changes
- Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning A-Share Repurchase
Follow Jiangsu Hengrui Pharmaceuticals into a list and get an email when it puts out news.
Follow Jiangsu Hengrui Pharmaceuticals